97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-000967-40-NL
(EUCTR)
03/11/200830/05/2008A Phase 2a Randomised, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderatley Active Ulcerative ColitisA Phase 2a Randomised, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderatley Active Ulcerative Colitis Moderately Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
ActoGeniX NV.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
60Phase 2Netherlands;Belgium;Sweden
2EUCTR2008-000967-40-SE
(EUCTR)
29/08/200804/06/2008A Phase 2a Randomised, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderatley Active Ulcerative ColitisA Phase 2a Randomised, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderatley Active Ulcerative Colitis Moderately Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
ActoGeniX NV.NULLNot RecruitingFemale: yes
Male: yes
60Phase 2Netherlands;Belgium;Sweden
3NCT00729872
(ClinicalTrials.gov)
July 20084/8/2008A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative ColitisA Phase 2a Randomized, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects With Moderately Active Ulcerative ColitisModerately Active Ulcerative ColitisBiological: AG011;Other: PlaceboActoGeniX N.V.NULLCompleted18 YearsN/ABoth60Phase 1/Phase 2Belgium;Canada;Netherlands;Sweden
4EUCTR2008-000967-40-BE
(EUCTR)
13/06/200805/08/2008A Phase 2a Randomized, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderately Active Ulcerative ColitisA Phase 2a Randomized, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects with Moderately Active Ulcerative Colitis Moderately Active Ulcerative Colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Enema
Product Code: AG011
Product Name: AG011 - Capsules
Product Code: AG011
ActoGeniX N.VNULLNot RecruitingFemale: yes
Male: yes
60Phase 2Netherlands;Belgium;Sweden